Nearly one in three women with autoimmune diseases waited at least four years for a diagnosis, survey finds
Oct 15 2026 From unexplained symptoms to repeated medical appointments, a survey of more than 6,600 patients examines…
Joe Manganiello says local shaman healed him from deadly condition
In a new memoir, Joe Manganiello is getting candid about the condition that nearly killed him and the…
Understanding type 1 diabetes risk through family narratives
Growing up with type 1 diabetes in the family may make the threat feel more familiar than frightening,…
Could a Potato Be the Key to New IBD Treatments?
For writer and speaker Amber Tresca, ulcerative colitis — an intestinal disorder — meant planning every moment of…
COVID-19 linked to lower subsequent risk of type 1 diabetes
New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes…
Landmark study identifies new genetic risk factors linked to fibromyalgia syndrome
In a landmark study published in Nature Medicine, an international team of researchers has identified new genetic risk…
Ultrasensitive Blood Test Detects Sjögren’s Disease Years Early, Study Finds
An ultrasensitive blood test could detect Sjögren’s disease more than a decade before a clinical diagnosis, according to…
Immune cells drive abnormal joint tissue growth in rheumatoid arthritis
Researchers at Hospital for Special Surgery (HSS) have identified a specialized population of immune cells that play a…
GLP-1 medicines may cut clot-related risks in chronically inflamed patients
A large real-world analysis suggests GLP-1 receptor agonists may offer clot-related and survival benefits in a chronically inflamed,…
GLP-1-based meds linked to fewer heart events in adults with obesity, autoimmune disease
Research Highlights:
Among people with both obesity and an autoimmune disease, those taking GLP-1-based medications had fewer…
Study reveals why women face higher autoimmune disease risks
Ahead of World Lupus Day on May 10, new research from the Garvan Institute of Medical Research and…
What’s the Next Big Thing After GLP-1 Drugs? CRISPR Therapeutics May Have the Answer.
Investors are always on the lookout for the next revolutionary technology or product. In recent times, this has…